- Report
- January 2026
- 130 Pages
Global
From €4235EUR$4,750USD£3,658GBP
- Report
- June 2025
- 400 Pages
Global
From €4412EUR$4,949USD£3,811GBP
- Report
- June 2025
- 400 Pages
Global
From €4412EUR$4,949USD£3,811GBP
- Report
- June 2025
- 400 Pages
Global
From €4412EUR$4,949USD£3,811GBP
- Report
- July 2025
- 295 Pages
Global
From €4453EUR$4,995USD£3,847GBP
- Report
- January 2026
- 148 Pages
Global
From €3522EUR$3,950USD£3,042GBP
- Report
- January 2026
- 145 Pages
Global
From €3522EUR$3,950USD£3,042GBP
- Report
- November 2025
- 150 Pages
Global
From €4324EUR$4,850USD£3,735GBP
- Report
- August 2025
- 150 Pages
Global
From €2993EUR$3,358USD£2,586GBP
€3522EUR$3,950USD£3,042GBP
- Report
- February 2026
- 194 Pages
Global
From €4453EUR$4,995USD£3,847GBP
- Report
- January 2026
- 200 Pages
Global
From €4453EUR$4,995USD£3,847GBP
- Report
- June 2025
- 209 Pages
Global
From €4453EUR$4,995USD£3,847GBP
- Report
- January 2026
- 160 Pages
Global
From €2994EUR$3,358USD£2,586GBP
€3522EUR$3,950USD£3,042GBP
- Report
- November 2025
- 160 Pages
Global
From €2993EUR$3,358USD£2,586GBP
€3522EUR$3,950USD£3,042GBP
- Report
- October 2025
- 160 Pages
Global
From €2993EUR$3,358USD£2,586GBP
€3522EUR$3,950USD£3,042GBP
- Report
- October 2025
- 160 Pages
Global
From €2993EUR$3,358USD£2,586GBP
€3522EUR$3,950USD£3,042GBP
- Report
- October 2025
- 160 Pages
Global
From €2993EUR$3,358USD£2,586GBP
€3522EUR$3,950USD£3,042GBP
- Report
- October 2025
- 160 Pages
Global
From €2993EUR$3,358USD£2,586GBP
€3522EUR$3,950USD£3,042GBP
- Report
- October 2025
- 160 Pages
Global
From €2993EUR$3,358USD£2,586GBP
€3522EUR$3,950USD£3,042GBP
- Report
- October 2025
- 160 Pages
Global
From €2993EUR$3,358USD£2,586GBP
€3522EUR$3,950USD£3,042GBP

Biomanufacturing is a sub-sector of biotechnology that focuses on the production of biopharmaceuticals, medical devices, and other products derived from living organisms. It involves the use of biotechnology processes such as genetic engineering, cell culture, and fermentation to produce these products. The biomanufacturing market is driven by the increasing demand for biopharmaceuticals, medical devices, and other products derived from living organisms. This demand is driven by the growing prevalence of chronic diseases, the increasing aging population, and the need for more effective treatments.
The biomanufacturing market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include Amgen, Merck, Novartis, Pfizer, and Roche. Other companies in the market include AbbVie, AstraZeneca, Biogen, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more